Cargando…

Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies

SIMPLE SUMMARY: Colorectal cancer (CRC) is a leading cause of death among cancer patients, and the liver is the most common visceral metastatic site. Despite promising advances in treatment, recurrences with the eventual progression of disease or liver failure are common. Molecular cancer biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitsel, Yuliya, Cooke, Timothy, Sotirchos, Vlasios, Sofocleous, Constantinos T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046329/ https://www.ncbi.nlm.nih.gov/pubmed/36980565 http://dx.doi.org/10.3390/cancers15061679

Ejemplares similares

3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases
por: Kamarinos, Nikiforos Vasiniotis, et al.
Publicado: (2022)

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla
por: Sotirchos, Vlasios S., et al.
Publicado: (2014)

PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases
por: Ziv, Etay, et al.
Publicado: (2017)

Real-Time Split-Dose PET/CT-Guided Ablation Improves Colorectal Liver Metastasis Detection and Ablation Zone Margin Assessments without the Need for Repeated Contrast Injection
por: Zirakchian Zadeh, Mahdi, et al.
Publicado: (2022)

The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
por: Filippiadis, Dimitrios K., et al.
Publicado: (2021)

Reducing Wait Times for Radiology Exams Around Holiday Periods: A Monte Carlo Simulation
por: Pisharody, Vivek A., et al.
Publicado: (2022)

The Role of Biomarkers in the Management of Colorectal Liver Metastases
por: Hewitt, Daniel Brock, et al.
Publicado: (2022)

Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases
por: Shady, Waleed, et al.
Publicado: (2017)

Colorectal Liver Metastases
por: Haddad, Ashraf J., et al.
Publicado: (2011)

Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases
por: Vasiniotis Kamarinos, Nikiforos, et al.
Publicado: (2022)

Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
por: Wang, Chengxing, et al.
Publicado: (2021)

Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022)

Prognostic circulating proteomic biomarkers in colorectal liver metastases
por: Kim, Dongchan, et al.
Publicado: (2023)

Is microwave ablation therapy as effective as colorectal liver metastases in noncolorectal liver metastases?
por: DANIŞAN, Gürkan, et al.
Publicado: (2022)

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases
por: Dendy, Meaghan S., et al.
Publicado: (2018)

Tailored Systemic Therapy for Colorectal Cancer Liver Metastases
por: Czauderna, Carolin, et al.
Publicado: (2021)

Arterial Therapies of Non-Colorectal Liver Metastases
por: Puippe, Gilbert, et al.
Publicado: (2015)

Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases
por: Zhang, Tianhao, et al.
Publicado: (2021)

Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
por: Michal, Sternschuss, et al.
Publicado: (2021)

Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients
por: Diep, Chieu B, et al.
Publicado: (2004)

Molecular Mechanisms of Colorectal Liver Metastases
por: Tsilimigras, Diamantis I., et al.
Publicado: (2023)

Genomic characterization of liver metastases from colorectal cancer patients
por: Sayagués, José María, et al.
Publicado: (2016)

Updates of colorectal cancer liver metastases therapy: review on DEBIRI
por: Fiorentini, Giammaria, et al.
Publicado: (2020)

B Cells as Prognostic Biomarker After Surgery for Colorectal Liver Metastases
por: Hof, Joost, et al.
Publicado: (2020)

Biomarkers in colorectal liver metastases: Rising complexity and unknown clinical significance?
por: Diener, Markus K., et al.
Publicado: (2021)

Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial
por: Mulcahy, Mary F., et al.
Publicado: (2021)

Macrophages in Colorectal Cancer Liver Metastases
por: Cortese, Nina, et al.
Publicado: (2019)

Colorectal Cancer, Liver Metastases and Biotherapies
por: Osei-Bordom, Daniel-Clement, et al.
Publicado: (2021)

Specific genomic aberrations in primary colorectal cancer are associated with liver metastases
por: Bruin, Sjoerd C, et al.
Publicado: (2010)

Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases
por: Wang, Hong-Wei, et al.
Publicado: (2021)

KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver
por: Popovic, M., et al.
Publicado: (2020)

Surgery for colorectal liver metastases
por: Primrose, J N
Publicado: (2010)

Treatment of colorectal liver metastases
por: Ismaili, Nabil
Publicado: (2011)

Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer
por: Froelich, Matthias F., et al.
Publicado: (2021)

Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation
por: Odet, Julien, et al.
Publicado: (2023)

Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation
por: Canseco, Lariza Marie, et al.
Publicado: (2023)

Limited Effect of Perioperative Systemic Therapy in Patients Selected for Repeat Local Treatment of Recurrent Colorectal Cancer Liver Metastases
por: Hellingman, Tessa, et al.
Publicado: (2022)

Irreversible electroporation in the treatment of locally advanced pancreas and liver metastases of colorectal carcinoma
por: Wichtowski, Mateusz, et al.
Publicado: (2016)

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases
por: Wensink, G E, et al.
Publicado: (2023)

Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l0jvd8ps2oi582i8hp9renf8na